Pacgen Biopharmaceuticals Corporation-B (02565.HK) completed the issuance of a total of 5,136,000 newly issued shares for sale.

Wisdom Finance APP News, Peg BioPharma-B (02565.HK) announced that all conditions of the placement agreement have been met, and the placement was completed on December 22, 2025. According to the terms and conditions of the placement agreement, the joint placement agents have placed a total of 5.136 million shares at a price of HK$58.41 per share to no fewer than 6 underwriters, representing approximately 1.81% of the H shares and 1.31% of the total number of shares after the placement.